| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of Health Sciences Research (Drs. Benedetti, Schaid, and Rocca, S.K. McDonnell, and B.J. Peterson) and Neurology (Drs. Maraganore, Bower, Ahlskog, and Rocca), Mayo Clinic and Mayo Foundation, Rochester, MN.
Address correspondence and reprint requests to Dr. W.A. Rocca, Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.
OBJECTIVE: To study the association of PD with preceding smoking, alcohol, and coffee consumption using a case-control design.
METHODS: The authors used the medical records linkage system of the Rochester Epidemiology Project to identify 196 subjects who developed PD in Olmsted County, MN, during the years 1976 to 1995. Each incident case was matched by age (±1 year) and sex to a general population control subject. The authors reviewed the complete medical records of cases and control subjects to abstract exposure information.
RESULTS: For coffee consumption, the authors found an OR of 0.35 (95% CI = 0.16 to 0.78, p = 0.01), a dose–effect trend (p = 0.003), and a later age at PD onset in cases who drank coffee compared with those who never did (median 72 versus 64 years; p = 0.0002). The inverse association with coffee remained significant after adjustment for education, smoking, and alcohol drinking and was restricted to PD cases with onset at age <72 years and to men. The OR for cigarette smoking was 0.69 (95% CI = 0.45 to 1.08, p = 0.1). The authors found no association between PD and alcohol consumption. Extreme or unusual behaviors such as tobacco chewing or snuff use and a diagnosis of alcoholism were significantly more common in control subjects than cases.
CONCLUSIONS: These findings suggest an inverse association between coffee drinking and PD; however, this association does not imply that coffee has a direct protective effect against PD. Alternative explanations for the association should be considered.
This article has been cited by other articles:
|
|
 |
|
  F D Dick, G De Palma, A Ahmadi, N W Scott, G J Prescott, J Bennett, S Semple, S Dick, C Counsell, P Mozzoni, et al. Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson study Occup. Environ. Med., October 1, 2007; 64(10): 666 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Ritz, A. Ascherio, H. Checkoway, K. S. Marder, L. M. Nelson, W. A. Rocca, G. W. Ross, D. Strickland, S. K. Van Den Eeden, and J. Gorell Pooled Analysis of Tobacco Use and Risk of Parkinson Disease Arch Neurol, July 1, 2007; 64(7): 990 - 997. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Thacker, E. J. O'Reilly, M. G. Weisskopf, H. Chen, M. A. Schwarzschild, M. L. McCullough, E. E. Calle, M. J. Thun, and A. Ascherio Temporal relationship between cigarette smoking and risk of Parkinson disease Neurology, March 6, 2007; 68(10): 764 - 768. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Xu, Y. Xu, D. Brown-Jermyn, J.-F. Chen, A. Ascherio, D. E. Dluzen, and M. A. Schwarzschild Estrogen Prevents Neuroprotection by Caffeine in the Mouse 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease J. Neurosci., January 11, 2006; 26(2): 535 - 541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Frigerio, A. Elbaz, K. R. Sanft, B. J. Peterson, J. H. Bower, J. E. Ahlskog, B. R. Grossardt, M. de Andrade, D. M. Maraganore, and W. A. Rocca Education and occupations preceding Parkinson disease: A population-based case-control study Neurology, November 22, 2005; 65(10): 1575 - 1583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.C. Williams, L.S. Cartwright, and D.B. Ramsden Parkinson's disease: the first common neurological disease due to auto-intoxication? QJM, March 1, 2005; 98(3): 215 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Chen, S. M. Zhang, M. A. Schwarzschild, M. A. Hernan, and A. Ascherio Physical activity and the risk of Parkinson disease Neurology, February 22, 2005; 64(4): 664 - 669. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. K. Scott, F. Zhang, J. M. Stajich, B. L. Scott, M. A. Stacy, and J. M. Vance Family-based case-control study of cigarette smoking and Parkinson disease Neurology, February 8, 2005; 64(3): 442 - 447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ascherio, M. G. Weisskopf, E. J. O'Reilly, M. L. McCullough, E. E. Calle, C. Rodriguez, and M. J. Thun Coffee Consumption, Gender, and Parkinson's Disease Mortality in the Cancer Prevention Study II Cohort: The Modifying Effects of Estrogen Am. J. Epidemiol., November 15, 2004; 160(10): 977 - 984. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ascherio and H. Chen Caffeinated clues from epidemiology of Parkinson's disease Neurology, December 9, 2003; 61(90116): S51 - 54. [Full Text]
|
|
|
|
|
|
A. Ascherio, H. Chen, M.A. Schwarzschild, S.M. Zhang, G.A. Colditz, and F.E. Speizer Caffeine, postmenopausal estrogen, and risk of Parkinson's disease Neurology, March 11, 2003; 60(5): 790 - 795. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F.-M. Zhou, C. Wilson, and J. A. Dani Muscarinic and Nicotinic Cholinergic Mechanisms in the Mesostriatal Dopamine Systems Neuroscientist, February 1, 2003; 9(1): 23 - 36. [Abstract] [PDF]
|
|
|
|
|
|
A. Elbaz, J. H. Bower, B. J. Peterson, D. M. Maraganore, S. K. McDonnell, J. E. Ahlskog, D. J. Schaid, and W. A. Rocca Survival Study of Parkinson Disease in Olmsted County, Minnesota Arch Neurol, January 1, 2003; 60(1): 91 - 96. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Schwarzschild, J.-F. Chen, and A. Ascherio Caffeinated clues and the promise of adenosine A2A antagonists in PD Neurology, April 23, 2002; 58(8): 1154 - 1160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Checkoway, K. Powers, T. Smith-Weller, G. M. Franklin, W. T. Longstreth Jr., and P. D. Swanson Parkinson's Disease Risks Associated with Cigarette Smoking, Alcohol Consumption, and Caffeine Intake Am. J. Epidemiol., April 15, 2002; 155(8): 732 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Tanner, S. M. Goldman, D. A. Aston, R. Ottman, J. Ellenberg, R. Mayeux, and J. W. Langston Smoking and Parkinson's disease in twins Neurology, February 26, 2002; 58(4): 581 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Deleu, W. A. Rocca, D. M. Maraganore, and M. D. Benedetti Smoking, alcohol, and coffee consumption preceding Parkinson's disease Neurology, April 10, 2001; 56(7): 984 - 985. [Full Text] [PDF]
|
|
|
|
|
|
J.-F. Chen, K. Xu, J. P. Petzer, R. Staal, Y.-H. Xu, M. Beilstein, P. K. Sonsalla, K. Castagnoli, N. Castagnoli Jr, and M. A. Schwarzschild Neuroprotection by Caffeine and A2A Adenosine Receptor Inactivation in a Model of Parkinson's Disease J. Neurosci., May 15, 2001; 21(10): RC143 - RC143. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
